Mirum Pharmaceuticals Inc (NAS:MIRM)
$ 41.56 -0.47 (-1.12%) Market Cap: 2.02 Bil Enterprise Value: 2.06 Bil PE Ratio: 0 PB Ratio: 8.69 GF Score: 51/100

Q3 2021 Mirum Pharmaceuticals Inc Earnings Call Transcript

Nov 15, 2021 / 09:30PM GMT
Release Date Price: $15.49 (-2.46%)
Operator

Hello, everyone, and welcome to the Mirum Pharmaceuticals Third Quarter Business Update Conference Call. My name is Victoria, and I'll be coordinating your call today. (Operator Instructions).

I will now hand over to your host, Ian Clements, Chief Financial Officer. Ian, please go ahead.

Ian Clements
Mirum Pharmaceuticals, Inc. - CFO

Thank you, Joy, and good afternoon, everyone. I'd like to welcome you to Mirum Pharmaceuticals Third Quarter 2021 Conference Call. I'm joined today by our President and CEO, Chris Peetz; Pam vig, Head of Research and Development; and Peter Radovich, Chief Operating Officer.

Earlier this afternoon, Mirum issued a news release announcing the company's results for the quarter ended September 30, 2021. Copies of this news release and SEC filings can be found in the Investors section of our website. Before we begin, I'd like to remind you that during the course of this conference call, we will be making certain forward-looking statements about Mirum and our progress -- and our programs based on management's current

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot